Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LGND | AMGN | GILD | CELG | ILMN |
| Company | Ligand Pharm | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 74.37 | 300.12 | 65.57 | 108.01 | 111.31 |
| High | 81.43 | 307.57 | 65.61 | 108.59 | 112.17 |
| Low | 72.95 | 298.89 | 64.76 | 107.27 | 108.54 |
| Last | 80.36 | 307.31 | 64.92 | 108.24 | 110.62 |
| Change | +7.14 | +7.01 | -0.54 | +0.11 | -2.20 |
| % Change | +9.75% | +2.33% | -0.82% | +0.10% | -1.95% |
| Volume | 286,900 | 2,859,500 | 5,134,900 | 191,230,496 | 2,848,800 |
| 20-Day Average Volume | 156,205 | 2,869,700 | 7,463,450 | 16,188,930 | 1,614,610 |
| Previous Close | 73.22 | 300.30 | 65.46 | 108.13 | 112.82 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 74.06 | 277.32 | 66.30 | 108.17 | 120.84 |
| 20-Day Raw Stochastic | 90.22% | 75.31% | 12.57% | 63.25% | 7.91% |
| 20-Day Relative Strength | 60.80% | 65.94% | 32.77% | 64.69% | 34.99% |
| Weighted Alpha | +16.08 | +32.33 | -21.04 | +46.30 | -45.55 |
| Today's Opinion | 80% Buy | 56% Buy | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 24% Buy | 40% Buy | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 88% Buy | 8% Sell | 100% Sell | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.52% since 05/01/24 | +10.79% since 05/01/24 | -0.90% since 05/01/24 | -1.97% since 11/13/19 | -11.28% since 05/01/24 |
| Low | 70.86 on 05/02/24 | 274.90 on 05/02/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 108.54 on 05/08/24 |
| High | 81.43 on 05/08/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 110.53 on 11/14/19 | 127.89 on 05/03/24 |
| 1-Month | |||||
| %Chg | +0.95% since 04/08/24 | +14.16% since 04/08/24 | -6.48% since 04/08/24 | +5.14% since 10/18/19 | -14.99% since 04/08/24 |
| Low | 67.72 on 04/22/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 108.54 on 05/08/24 |
| High | 81.73 on 04/12/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 110.70 on 11/13/19 | 135.26 on 04/09/24 |
| 3-Month | |||||
| %Chg | +6.56% since 02/08/24 | +4.23% since 02/08/24 | -12.03% since 02/08/24 | +13.63% since 08/20/19 | -22.82% since 02/08/24 |
| Low | 67.72 on 04/22/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 108.54 on 05/08/24 |
| High | 94.57 on 02/27/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 147.70 on 02/09/24 |
| 6-Month | |||||
| %Chg | +53.86% since 11/08/23 | +12.46% since 11/08/23 | -16.66% since 11/08/23 | +14.14% since 05/20/19 | -0.07% since 11/08/23 |
| Low | 51.21 on 11/09/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 94.57 on 02/27/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,296,360 | 161,091,424 | 81,502,736 | 77,035,920 | 17,972,226 |
| Shares Outstanding, K | 17,705 | 536,435 | 1,245,077 | 711,714 | 159,300 |
| Annual Sales | 131,310,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | 52,150,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 28,100,000 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 1,076,000,000 |
| Last Quarter Net Income | 18,190,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | -126,000,000 |
| 60-Month Beta | 1.01 | 0.60 | 0.22 | 1.41 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | 3.84 on 05/07/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 0.09 on 05/02/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | 2.500 on 04/03/07 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 15.97 | 16.08 | 16.26 | 10.99 | 135.20 |